文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

纤维蛋白单体预测重型颅脑创伤患者进展性出血性损伤的能力

Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.
PubMed 文献 · Neurocrit Care · 2020-01-01
一句话结论重型颅脑创伤患者入院时纤维蛋白单体≥131.7 μg/ml 独立关联进展性出血性损伤(OR 6.8),阈值阴性预测值94%。

该前瞻性观察研究纳入重型颅脑创伤患者,推导队列106例(2011年9月至2016年9月),验证队列54例(2016年10月至2018年12月)。入院时检测纤维蛋白单体及标准凝血试验,并在到达时及至少6小时后行两次CT。推导队列中50.9%发生进展性出血性损伤,纤维蛋白单体预测的AUC为0.7(95%CI 0.6-0.79),最佳阈值131.7 μg/ml。验证队列中该阈值阴性预测值94%(95%CI 71-100),阳性预测值49%(95%CI 32-66)。多因素分析显示纤维蛋白单体≥131.7 μg/ml(OR 6.8;95%CI 2.8-18.1)和Marshall分型(OR 1.7;95%CI 1.3-2.2)与进展性出血性损伤独立相关,而凝血病与进展性出血性损伤无关(OR 1.3;95%CI 0.5-3.0)。纤维蛋白单体阳性患者6个月不良功能预后比例更高(62.1% vs 29.1%,p<0.0001)。

要点

  • 重型颅脑创伤患者入院纤维蛋白单体≥131.7 μg/ml 独立关联进展性出血性损伤,OR 6.8(95%CI 2.8-18.1)。
  • 纤维蛋白单体预测进展性出血性损伤的AUC为0.7(95%CI 0.6-0.79),准确性一般。
  • 验证队列中阈值131.7 μg/ml 的阴性预测值94%(95%CI 71-100),阳性预测值49%(95%CI 32-66)。
  • Marshall分型每增加一级,进展性出血性损伤风险 OR 1.7(95%CI 1.3-2.2)。
  • 纤维蛋白单体阳性患者6个月不良功能预后比例62.1% vs 29.1%(p<0.0001)。

适用人群与场景

  • 于创伤中心收治的重型颅脑创伤患者,推导队列纳入时间为2011年9月至2016年9月,验证队列为2016年10月至2018年12月。

诊断标准与关键阈值

  • 进展性出血性损伤定义为随访CT较初始CT初始病灶增大25%或以上,或出现新发出血。
  • 纤维蛋白单体预测进展性出血性损伤的最佳阈值为131.7 μg/ml。

研究设计与关键结果

  • 前瞻性观察研究,推导队列106例,其中54例(50.9%)发生进展性出血性损伤;发生者纤维蛋白单体值更高(151 [136.8-151] vs 120.5 [53.3-151],p<0.0001)。
  • 纤维蛋白单体预测进展性出血性损伤的ROC曲线AUC为0.7(95%CI 0.6-0.79),最佳阈值131.7 μg/ml。
  • 验证队列54例中,阈值131.7 μg/ml 的阴性预测值为94%(95%CI 71-100),阳性预测值为49%(95%CI 32-66)。
  • 多因素logistic回归显示与进展性出血性损伤相关的参数:纤维蛋白单体≥131.7 μg/ml(OR 6.8;95%CI 2.8-18.1)和Marshall分型(OR 1.7;95%CI 1.3-2.2);凝血病与进展性出血性损伤无关(OR 1.3;95%CI 0.5-3.0)。
  • 6个月随访时,纤维蛋白单体阳性患者不良功能神经预后比例高于阴性患者:59例(62.1%) vs 16例(29.1%),p<0.0001。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究,包含推导队列和验证队列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为入院纤维蛋白单体水平对预测重型颅脑创伤后进展性出血性损伤具有一般准确性。
  • 作者认为纤维蛋白单体≥131.7 μg/ml 与进展性出血性损伤的发生独立相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Progressive hemorrhagic injury (PHI) is common in patients with severe traumatic brain injury (TBI) and is associated with poor outcomes. TBI-associated coagulopathy is frequent and has been described as risk factor for PHI. This coagulopathy is a dynamic process involving hypercoagulable and hypocoagulable states either one after the other either concomitant. Fibrin monomers (FMs) are a direct marker of thrombin action and thus reflect coagulation activation. This study sought to determine the ability of FM to predict PHI after severe TBI.

METHODS: We conducted a prospective, observational study including all severe TBI patients admitted in the trauma center. Between September 2011 and September 2016, we enrolled patients with severe TBI into the derivation cohort. Between October 2016 and December 2018, we recruited the validation cohort on the same basis. Study protocol included FM measurements and standard coagulation test at admission and two computed tomography (CT) scans (upon arrival and at least 6 h thereafter). A PHI was defined by an increment in size of initial lesion (25% or more) or the development of a new hemorrhage in the follow-up CT scan. Multivariate logistic regression analysis was applied to identify predictors of PHI.

RESULTS: Overall, 106 patients were included in the derivation cohort. Fifty-four (50.9%) experienced PHI. FM values were higher in these patients (151 [136.8-151] vs. 120.5 [53.3-151], p < 0.0001). The ROC curve demonstrated that FM had a fair accuracy to predict the occurrence of PHI with an area under curve of 0.7 (95% CI [0.6-0.79]). The best threshold was determined at 131.7 μg/ml. In the validation cohort of 54 patients, this threshold had a negative predictive value of 94% (95% CI [71-100]) and a positive predictive value of 49% (95% CI [32-66]). The multivariate logistic regression analysis identified 2 parameters associated with PHI: FM ≥ 131.7 (OR 6.8; 95% CI [2.8-18.1]) and Marshall category (OR 1.7; 95% CI [1.3-2.2]). Coagulopathy was not associated with PHI (OR 1.3; 95% CI [0.5-3.0]). The proportion of patients with an unfavorable functional neurologic outcome at 6-months follow-up was higher in patients with positive FM: 59 (62.1%) versus 16 (29.1%), p < 0.0001.

CONCLUSIONS: FM levels at admission had a fair accuracy to predict PHI in patients with severe TBI. FM values ≥ 131.7 μg/ml are independently associated with the occurrence of PHI.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Esnault P, Mathais Q, D'Aranda E, et al. Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury. Neurocrit Care. 2020. PMID: 31797276. doi:10.1007/s12028-019-00882-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。